EE9700079A - Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod - Google Patents

Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod

Info

Publication number
EE9700079A
EE9700079A EE9700079A EE9700079A EE9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A
Authority
EE
Estonia
Prior art keywords
azaindole
pyrimido
cycloalkane
indole
preparation
Prior art date
Application number
EE9700079A
Other languages
English (en)
Estonian (et)
Inventor
Lenfers Jan-Bernd
Fey Peter
Naab Paul
Van Laak Kai
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE9700079A publication Critical patent/EE9700079A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/65Halogen-containing esters of unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700079A 1996-04-04 1997-04-03 Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod EE9700079A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613549A DE19613549A1 (de) 1996-04-04 1996-04-04 Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate

Publications (1)

Publication Number Publication Date
EE9700079A true EE9700079A (et) 1997-10-15

Family

ID=7790501

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700079A EE9700079A (et) 1996-04-04 1997-04-03 Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod

Country Status (27)

Country Link
US (1) US5952498A (fr)
EP (1) EP0799829B1 (fr)
JP (2) JP4235268B2 (fr)
KR (1) KR970069988A (fr)
CN (2) CN1067394C (fr)
AR (2) AR006544A1 (fr)
AT (1) ATE246193T1 (fr)
AU (1) AU722592B2 (fr)
BR (1) BR9701672A (fr)
CA (1) CA2201435C (fr)
CZ (1) CZ102197A3 (fr)
DE (2) DE19613549A1 (fr)
DZ (1) DZ2202A1 (fr)
EE (1) EE9700079A (fr)
ES (1) ES2202506T3 (fr)
HR (1) HRP970178A2 (fr)
HU (1) HU218494B (fr)
ID (1) ID16794A (fr)
IL (1) IL120591A (fr)
MA (1) MA24130A1 (fr)
NO (2) NO308301B1 (fr)
NZ (1) NZ314498A (fr)
PL (1) PL319269A1 (fr)
SG (1) SG60050A1 (fr)
SK (1) SK42897A3 (fr)
TN (1) TNSN97060A1 (fr)
ZA (1) ZA972831B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
WO2001074817A1 (fr) * 2000-03-30 2001-10-11 Yamanouchi Pharmaceutical Co., Ltd. Derives d'hydrazide
WO2005051382A1 (fr) * 2003-11-28 2005-06-09 Astellas Pharma Inc. Agent renforçant l'effet hypolipidemiant
CA2910191C (fr) 2004-03-05 2022-03-08 The Trustees Of The Univeristy Of Pennsylvania L'utilisation d'inhibiteurs mtp pour le traitement a faibles effets secondaires contre des affections liees a l'hyperlipidemie et l'hypercholesterolemie
US20080280922A1 (en) * 2004-04-09 2008-11-13 Marc Alois Celine Maria Engelen Intermittent Dosing Regimen For Overweight and Obese Subjects
CA2626441A1 (fr) * 2005-10-18 2007-04-26 Aegerion Pharmaceuticals Methodes permettant de traiter les troubles associes a l'hyperlipidemie chez un mammifere
EP2040704A2 (fr) * 2006-05-18 2009-04-01 Bayer Healthcare Ag Compositions pharmaceutiques contenant du implitapide et leurs méthodes d'application
US20080161279A1 (en) * 2006-12-21 2008-07-03 Wisler Gerald L Methods of Treating Obesity
WO2008124384A2 (fr) * 2007-04-03 2008-10-16 Aegerion Pharmaceuticals, Inc. Méthodes de traitement de l'hépatite c
CN105120863B (zh) 2013-03-14 2021-06-04 奥斯特克有限公司 促进骨生长的烷基胺骆驼蓬碱衍生物
ES3004565T3 (en) 2018-08-14 2025-03-12 Ossifi Therapeutics Llc Pyrrolo - dipyridine compounds for the treatment of bone loss
CN113166058A (zh) 2018-08-14 2021-07-23 奥斯特克有限公司 氟β-咔啉化合物
CA3186856A1 (fr) 2020-07-29 2022-02-03 Ruth NALLEN Lomitapide destine a etre utilise dans des methodes de traitement de l'hyperlipidemie et de l'hypercholesterolemie chez des patients pediatriques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate

Also Published As

Publication number Publication date
HRP970178A2 (en) 1998-04-30
EP0799829B1 (fr) 2003-07-30
IL120591A0 (en) 1997-08-14
HU9700698D0 (en) 1997-05-28
US5952498A (en) 1999-09-14
IL120591A (en) 2000-11-21
HU218494B (hu) 2000-09-28
MA24130A1 (fr) 1997-10-01
SG60050A1 (en) 1999-02-22
CN1067394C (zh) 2001-06-20
MX9702446A (es) 1997-10-31
DZ2202A1 (fr) 2002-12-03
CN1184109A (zh) 1998-06-10
JP2008169218A (ja) 2008-07-24
AR006544A1 (es) 1999-09-08
NO20003784D0 (no) 2000-07-24
JP4235268B2 (ja) 2009-03-11
NO971513L (no) 1997-10-06
DE59710487D1 (de) 2003-09-04
AU722592B2 (en) 2000-08-10
ID16794A (id) 1997-11-13
CN1330065A (zh) 2002-01-09
EP0799829A1 (fr) 1997-10-08
AR012048A2 (es) 2000-09-27
SK42897A3 (en) 1997-10-08
NZ314498A (en) 1999-09-29
AU1660297A (en) 1997-10-09
NO971513D0 (no) 1997-04-03
PL319269A1 (en) 1997-10-13
NO308301B1 (no) 2000-08-28
ES2202506T3 (es) 2004-04-01
CZ102197A3 (en) 1997-10-15
NO20003784L (no) 1997-10-06
TNSN97060A1 (fr) 2005-03-15
CA2201435C (fr) 2006-12-12
BR9701672A (pt) 1998-11-03
DE19613549A1 (de) 1997-10-09
KR970069988A (ko) 1997-11-07
CA2201435A1 (fr) 1997-10-04
HUP9700698A1 (hu) 1998-01-28
ZA972831B (en) 1997-10-31
ATE246193T1 (de) 2003-08-15
JPH1045759A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
NO986051D0 (no) Antikonvulsive derivater for behandling av manisk-depressive mangler
FI973059A7 (fi) Menetelmä peryleeni-3,4-dikarboksyylihappoimidien valmistamiseksi ja p uhdistamiseksi
FI945363L (fi) Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä
EE9700079A (et) Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod
AU6257594A (en) Indole derivatives as antagonists of excitatory amino acids
FI972919A0 (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
DE59509556D1 (de) Verfahren zur Herstellung von Perylenimiden, neue di-, tri- und tetrachromophore Perylenfarbstoffe und deren Verwendung
EE9700078A (et) Pürimido(1,2-a)indoolid, nende valmistamismeetod, kasutamine ravimite valmistamiseks,nimetatud indoole sisaldavad ravimid ning indoolide valmistamiseks kasutatavad karboksüülhapped ja nende valmistamismeetod
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI894506L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia pyrido/1,2-a/indolijohdannaisia
NO952713L (no) Fremgangsmåte for fremstilling av substituerte indolonderivater
HUP9903988A3 (en) Process for the preparation of an inorganic salt of optically active phenylglycine derivative
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO942381L (no) Fremgangsmåte for fremstilling av indoler
NO932783D0 (no) Fremgangsmaate for fremstilling av imidazopyridiner
FI910448A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
FI951047A0 (fi) Menetelmä indolijohdannaisten valmistamiseksi
FI963808A7 (fi) Menetelmä (1H-tetratsol-5-yyli)tetratsolo(1,5-a)kinoliinien ja naftyri diinien valmistamiseksi
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
EP0714659A3 (fr) Dérivés d'indole dans le traitement de l'emesis
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
AU2233097A (en) Process for the preparation of optically active indole compounds
IL136922A0 (en) Process for the preparation of enantiomerically pure indolecarboxylic acid derivatives and some such new compounds